scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1045139338 |
P356 | DOI | 10.1208/S12249-010-9548-Z |
P932 | PMC publication ID | 3011074 |
P698 | PubMed publication ID | 21136309 |
P5875 | ResearchGate publication ID | 49662767 |
P2093 | author name string | Doaa Ahmed El-Setouhy | |
Mohamed El-Nabarawi | |||
Magdy M Ibrahim | |||
Montasir A Fadlalla | |||
P2860 | cites work | Design, synthesis and in vitro evaluation of novel water-soluble prodrugs of buparvaquone. | Q30966309 |
Production and characterization of Hesperetin nanosuspensions for dermal delivery | Q33402012 | ||
Fast-dissolve drug delivery systems. | Q33885861 | ||
Improving drug solubility for oral delivery using solid dispersions | Q33935264 | ||
Etodolac. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain states | Q34591536 | ||
Nanosizing: a formulation approach for poorly-water-soluble compounds | Q35069024 | ||
Effectiveness of etodolac (‘Lodine’) compared with naproxen in patients with acute gout | Q39512505 | ||
Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo. | Q40017793 | ||
The concept of dissolution efficiency | Q40313091 | ||
Synthesis and cytotoxicity of water soluble quaternary salt derivatives of camptothecin | Q40540572 | ||
Comparison of the effect of tromethamine and polyvinylpyrrolidone on dissolution properties and analgesic effect of nimesulide. | Q41989862 | ||
Enhanced oral bioavailability of etodolac by self-emulsifying systems: in-vitro and in-vivo evaluation | Q43058476 | ||
Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs | Q44275399 | ||
Development and characterization of naproxen-chitosan solid systems with improved drug dissolution properties | Q44428858 | ||
Chemopreventative effect of a cyclooxygenase-2-specific inhibitor (etodolac) on chemically induced biliary carcinogenesis in hamsters | Q45119225 | ||
Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions | Q45524973 | ||
Enhancement of dissolution rate of piroxicam using liquisolid compacts | Q46452274 | ||
Preparation and characterization of uniform nanosized cephradine by combination of reactive precipitation and liquid anti-solvent precipitation under high gravity environment | Q46627199 | ||
Dissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers | Q46794408 | ||
Biopharmaceutics classification system: the scientific basis for biowaiver extensions | Q74614652 | ||
Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine) | Q80325417 | ||
Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs | Q82965679 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1730-1737 | |
P577 | publication date | 2010-12-07 | |
P1433 | published in | AAPS PharmSciTech | Q15750612 |
P1476 | title | Polymeric surfactant based etodolac chewable tablets: formulation and in vivo evaluation | |
P478 | volume | 11 |
Search more.